FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy
In December 2019, a novel SARS-CoV-2 coronavirus emerged, causing an outbreak of life-
threatening pneumonia in the Hubei province, China, and has now spread worldwide …
threatening pneumonia in the Hubei province, China, and has now spread worldwide …
An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment
The COVID-19 pandemic is one of the greatest threats to human health in the 21st century
with more than 257 million cases and over 5.17 million deaths reported worldwide (as of …
with more than 257 million cases and over 5.17 million deaths reported worldwide (as of …
Systematic review on the therapeutic options for COVID-19: clinical evidence of drug efficacy and implications
Abstract A novel coronavirus-2 (SARS-CoV-2) was first identified in Wuhan, China, and
quickly spread globally. Several treatments have been proposed, many of which have …
quickly spread globally. Several treatments have been proposed, many of which have …
Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses
Coronaviridae is a peculiar viral family, with a very large RNA genome and characteristic
appearance, endowed with remarkable tendency to transfer from animals to humans. Since …
appearance, endowed with remarkable tendency to transfer from animals to humans. Since …
Old and re-purposed drugs for the treatment of COVID-19
SS Jean, PR Hsueh - Expert review of anti-infective therapy, 2020 - Taylor & Francis
Introduction: The coronavirus disease 2019 (COVID-19) caused by the novel severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has developed since December 2019. It …
respiratory syndrome coronavirus 2 (SARS-CoV-2) has developed since December 2019. It …
Anti COVID-19 drugs: need for more clinical evidence and global action
Abstract The World Health Organization (WHO) called the outbreak of coronavirus infectious
disease-2019 (COVID-19) a “Public Health Emergency of International Concern”(PHEIC) …
disease-2019 (COVID-19) a “Public Health Emergency of International Concern”(PHEIC) …
Discovering drugs to treat coronavirus disease 2019 (COVID-19)
L Dong, S Hu, J Gao - Drug discoveries & therapeutics, 2020 - jstage.jst.go.jp
The SARS-CoV-2 virus emerged in December 2019 and then spread rapidly worldwide,
particularly to China, Japan, and South Korea. Scientists are endeavoring to find antivirals …
particularly to China, Japan, and South Korea. Scientists are endeavoring to find antivirals …
Current pharmacological treatments for SARS-COV-2: A narrative review
G Nittari, G Pallotta, F Amenta, SK Tayebati - European Journal of …, 2020 - Elsevier
The novel coronavirus, later identified as SARS-CoV-2, originating from Wuhan in China in
November 2019, quickly spread around the world becoming a pandemic. Despite the …
November 2019, quickly spread around the world becoming a pandemic. Despite the …
Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2)-an update on the status
TM Abd El-Aziz, JD Stockand - Infection, Genetics and Evolution, 2020 - Elsevier
Coronaviruses are a large group of viruses known to cause illnesses that vary between the
common cold and more severe diseases to include severe acute respiratory syndrome …
common cold and more severe diseases to include severe acute respiratory syndrome …
[HTML][HTML] Is hydroxychloroquine beneficial for COVID-19 patients?
The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) was first reported in December 2019. As similar …
syndrome coronavirus 2 (SARS-CoV-2) was first reported in December 2019. As similar …